- World rank, all time
- #32,684 of 42,892
- Rank in Spain
- #760 of 927
- Research works
- 142 ▲ 8% vs 2013–17
- Citations
- 2.9k 20.3 per fractional work
- Top-10% rate
- 12.6% record average 16.5%
- Open access
- 48% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.3×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 5.3×
- Immunology and Microbiology 3.9×
- Medicine 3.3×
- Pharmacology, Toxicology and Pharmaceutics 0.4×
- Economics, Econometrics and Finance 0.2×
- Chemistry 0.1×
- Engineering 0.1×
- Computer Science 0.1×
- Materials Science 0.1×
- Social Sciences 0.1×
- Environmental Science 0.0×
- Neuroscience 0.0×
Who are the top researchers at Instituto Oncológico Dr. Rosell?
Ranked on the composite score, Santiago Viteri, María González Cao and María González‐Cao lead among researchers whose main affiliation is Instituto Oncológico Dr. Rosell.
- 1 Santiago Viteri Spain · #156,603 worldwide 213 citations · 53 works
- 2 María González Cao Spain · #665,314 worldwide 36 citations · 17 works
- 3 María González‐Cao Spain · #863,991 worldwide 32 citations · 22 works
Which keywords describe research at Instituto Oncológico Dr. Rosell?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Targeted Therapy, Clinical Trials, Immunotherapy, Cancer, ALK Inhibitors, EGFR Mutations and Tumor Microenvironment.
- Small-Cell Lung Cancer
- Lung Cancer
- Genomic Profiles
- BRAF Mutation
- Medical Imaging
- Biogenesis
- Molecular Subtypes
- Cancer Genomics
- Immune Checkpoint Blockade
- Epidermal Niche
- Stem Cells
- Genomic Instability
- Tumor Staging
- Radiotherapy
- Metastasis
- Biomarkers
- Tumor Microenvironment
- ALK Inhibitors
- Immunotherapy
- Targeted Therapy
- Chemotherapy
- Clinical Trials
- Cancer
- EGFR Mutations
- Precision Medicine
- Survival Analysis
- Breast Cancer
- Regeneration
- Adjuvant Therapy
- Prognostic Factors
- Cell-Free DNA
- Hair Follicle
- PD-1 and PD-L1
- Clinical Practice Guidelines
- Mutational Signatures
- Cancer Therapy
- Metastatic Breast Cancer
- CT Screening
- Immunity
- Predictive Modeling
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy6▲ 26×15 topics
- Targeted Therapy6▲ 77×4 topics
- Clinical Trials5▲ 20×6 topics
- Immunotherapy4▲ 15×12 topics
- Cancer3▲ 7.3×22 topics
- ALK Inhibitors3▲ 150×1 topic
- EGFR Mutations3▲ 150×1 topic
- Tumor Microenvironment3▲ 19×8 topics
- Precision Medicine2▲ 15×5 topics
- Biomarkers2▲ 8.1×5 topics
- Survival Analysis2▲ 19×4 topics
- Metastasis2▲ 14×8 topics
- Breast Cancer2▲ 20×4 topics
- Radiotherapy2▲ 12×4 topics
- Regeneration2▲ 23×2 topics
- Tumor Staging2▲ 43×2 topics
- Adjuvant Therapy2▲ 35×2 topics
- Genomic Instability2▲ 39×2 topics
- Prognostic Factors2▲ 10×6 topics
- Stem Cells2▲ 17×2 topics
- Cell-Free DNA1▲ 41×2 topics
- Epidermal Niche1▲ 232×1 topic
- Hair Follicle1▲ 232×1 topic
- Immune Checkpoint Blockade1▲ 37×1 topic
- PD-1 and PD-L11▲ 37×1 topic
- Cancer Genomics1▲ 54×1 topic
- Clinical Practice Guidelines1▲ 7.1×4 topics
- Molecular Subtypes1▲ 47×2 topics
- Mutational Signatures1▲ 54×1 topic
- Biogenesis1▲ 20×3 topics
- Cancer Therapy1▲ 6.3×8 topics
- Medical Imaging1▲ 7.0×2 topics
- Metastatic Breast Cancer1▲ 62×2 topics
- BRAF Mutation1▲ 44×2 topics
- CT Screening1▲ 48×1 topic
- Genomic Profiles1▲ 79×1 topic
- Immunity1▲ 8.2×4 topics
- Lung Cancer1▲ 19×1 topic
- Predictive Modeling1▲ 12×2 topics
- Small-Cell Lung Cancer1▲ 79×1 topic
Which research topics does Instituto Oncológico Dr. Rosell publish most on?
By volume in 2022–2025: Lung Cancer Treatments and Mutations, Hair Growth and Disorders, Cancer Immunotherapy and Biomarkers and Cancer Genomics and Diagnostics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
- 2 Hair Growth and Disorders Urology 1 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 4 Cancer Genomics and Diagnostics Cancer Research 1 works
- 5 Lung Cancer Research Studies Oncology 1 works
- 6 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
- 7 Colorectal Cancer Treatments and Studies Oncology 1 works
- 8 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 1 works
- 9 HER2/EGFR in Cancer Research Oncology 1 works
- 10 Cancer therapeutics and mechanisms Molecular Biology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Instituto Oncológico Dr. Rosell's research output changed?
Output in 2018–2022 was 8% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Barcelona
- Universitat de Barcelona
- Universitat Politècnica de Catalunya
- Universitat Pompeu Fabra
- Hospital Clínic de Barcelona
- Vall d'Hebron Hospital Universitari
- Hospital de Sant Pau
- Universitat Oberta de Catalunya
- Institució Catalana de Recerca i Estudis Avançats
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.